Voluntary conversion of convertible bonds into shares

In 2023 Injeq Oyj organized a share issue between June 21 and August 28, when the company received capital investment worth €880,253.05. As the investment is worth less than two million euros, the share issue triggers a “Voluntary Conversion” into company shares in accordance with the terms of the convertible bond.

If you want to convert your Bond investment into shares, please indicate your willingness between October 27, 2023 and November 10, 2023 by sending an email to IR@injeq.com and stating that you want to convert your convertible bond into Injeq Oyj shares.

Note: If the investor’s place of residence is outside Finland and his/her/its foreign bank can’t take into custody unlisted Finnish securities, and the investor is unwilling or unable to open a bookentry account in Finland, the shares will be held in the administrative register instead of the book-entry system.

Conversion of convertible bond investment into shares

The company’s board of directors decided to start the voluntary conversion on October 27, 2023 and end it on November 10, 2023, in accordance with the terms of the convertible bond (VVK). The value date was decided on November 6, 2023, when the conversion corresponds to the latest share price in the share issue of €5.65/share, including a 20% discount and 8% annual (365 days) interest on the investment

Example:

Bond investment:   €1000
Accrued interest for the period March 23, 2022- November 6,2023 €129.97
Total convertible capital €1129.97
The share price in the previous issue was €5.65/share
20% reduced price €4.52 per share
Amount to be converted €1129.97 / €4.52 = 250 shares

 

Research news: A previous champagne tap reduces the probability of traumatic lumbar puncture in the following procedure

Injeq’s Harri Sievänen has publish new interesting findings about the incidence of traumatic lumbar punctures. “According to binary logistic regression, […]
Read more »

Injeq IQ-Tip device: Pre-launch in Kuwait

Injeq IQ-Tip was introduced to Kuwaiti doctors in October. Product Line Manager Mr Ahmed Jamous from Mareen Group had a […]
Read more »

Voluntary conversion of convertible bonds into shares

In 2023 Injeq Oyj organized a share issue between June 21 and August 28, when the company received capital investment […]
Read more »

Digital Healthcare – Matchmaking with hospitals in Vienna

Last week almost 60 Austrian healthcare professionals attended the matchmaking event organised by Business Finland and the Wiener Gesundheitsverbund on […]
Read more »

FDA grants breakthrough device designation for Injeq IQ-Tip® smart needle

Injeq is happy to announce that Injeq IQ-Tip device with its indications for use meet the criteria and have been […]
Read more »

Breakthrough Device designation granted by FDA

Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »